News

How to Invest in Mounjaro
Mounjaro is one of the bestselling weight loss drugs. See what your options are if you want to invest in Mounjaro stock.
Eli Lilly's Mounjaro KwikPen Approved In India For Diabetes And Obesity
Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...
Anti-obesity mkt heats up as Mounjaro's Kwikpen version gets India approval
Eli Lilly receives approval for Mounjaro in prefilled Kwikpen as competition intensifies in India's weight-loss drug market ...
Eli Lilly Mounjaro Sees Strong Reception in India, Rising Demand Amid Obesity, Diabetes Rates
Eli Lilly and Company (NYSE: LLY) is one of the best Fortune 500 stocks to buy according to billionaires. On June 20, Eli ...
Fierce Pharma4h
With China approval, Lilly and Innovent's mazdutide breaks into new class for GLP-1 obesity drugs
In a breakthrough for incretin medicines, China’s National Medical Products Administration (NMPA) has approved Innovent’s ...
Novo Nordisk launches weight-loss drug Wegovy in India to compete with Lilly's Mounjaro
Danish drugmaker Novo Nordisk on Tuesday launched its blockbuster weight-loss drug Wegovy in India, three months after Eli ...
inews.co.uk5h
GPs swamped by requests for NHS Mounjaro - but no one qualifies
Thousands taking Mounjaro privately are inundating GP surgeries - clogging phone lines, exacerbating the 8am scramble for ...
Experts warn of four 'red flag' side effects of Mounjaro as it's rolled out across UK
Mounjaro has now become available on the NHS for patients in the UK, meaning doctors will have a lot more work on their ...